Large-scale testing (Phase 3)Ended earlyNCT00462202
What this trial is testing
Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
Who this might be right for
Diabetic Nephropathy
Keryx Biopharmaceuticals 200